308 related articles for article (PubMed ID: 3918560)
1. Differentiation of patients with subtype IIb-like von Willebrand's disease by means of perfusion experiments with reconstituted blood.
Sakariassen KS; Nieuwenhuis HK; Sixma JJ
Br J Haematol; 1985 Mar; 59(3):459-70. PubMed ID: 3918560
[TBL] [Abstract][Full Text] [Related]
2. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
3. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
4. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
Weiss HJ; Sussman II
Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
[TBL] [Abstract][Full Text] [Related]
5. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
6. Abnormality of glycoprotein Ib in two cases of "pseudo"-von Willebrand's disease.
Bryckaert MC; Pietu G; Ruan C; Tobelem G; Girma JP; Meyer D; Larrieu MJ; Caen JP
J Lab Clin Med; 1985 Oct; 106(4):393-400. PubMed ID: 2931492
[TBL] [Abstract][Full Text] [Related]
7. A probable double heterozygous type II von Willebrand's disease with increased ristocetin induced platelet aggregation.
Kinoshita S; Yoshioka K; Kasahara M; Takamiya O
Am J Hematol; 1992 Jul; 40(3):192-8. PubMed ID: 1609773
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
9. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
[TBL] [Abstract][Full Text] [Related]
10. In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
d'Alessio PA; Castaman G; Rodeghiero F; de Boer HC; Federici AB; Mannucci PM; de Groot PG; Sixma JJ; Zwaginga JJ
Thromb Res; 1992 Jan; 65(2):221-8. PubMed ID: 1579897
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
12. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
[TBL] [Abstract][Full Text] [Related]
13. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
14. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
15. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
Niiya K; Kubonishi I; Taguchi H; Miyoshi I
Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
[TBL] [Abstract][Full Text] [Related]
16. Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome.
Weiss HJ
Blood; 1975 Mar; 45(3):403-12. PubMed ID: 1078779
[TBL] [Abstract][Full Text] [Related]
17. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
18. Association between bleeding time and platelet adherence to artery subendothelium.
Sakariassen KS; Bolhuis PA; Blombäck M; Thorell L; Blombäck B; Sixma JJ
Thromb Haemost; 1984 Oct; 52(2):144-7. PubMed ID: 6441301
[TBL] [Abstract][Full Text] [Related]
19. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]